
Calcium phosphate-polymer hybrid nanoparticles for enhanced triple negative breast cancer treatment via co-delivery of paclitaxel and miR-221/222 inhibitors
Keywords: miR; micro RNA; miRi; micro RNA inhibitor; pac; paclitaxel; ER; estrogen receptor; PR; progesterone receptor; HER2/neu; epidermal growth factor receptor 2; TNBC; triple-negative breast cancer; PLGA; poly(d,l-lactide-co-glycolide); PEG; poly(ethylene-glyco